Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.

Medicine (Baltimore) · 2016 · PMC4979821 · PMID 27495067

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

[ 16 , 27 , 28 ] Recent data have also suggested that HBV DNA and quantitative HBsAg levels are more likely to be significant contributors to HCC risk than ALT.

also in 986 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.